What happened
Researchers built an AI system that designs cyclic peptides (small proteins used in medicine) by explicitly showing its step-by-step reasoning about how to modify molecular structures, rather than just producing results as a black box. This makes drug design faster and more trustworthy because scientists can see why the AI chose each modification and verify it makes chemical sense.
Why it matters
For decades, drug designers have relied on either brute-force testing or AI systems that produce answers without explanation — making it hard to trust or learn from the results. This work shows AI can both optimize for useful drug properties AND show its work, which could compress the expensive, slow cycle of peptide-based drug discovery if the approach scales to real laboratory use.